Review – Treatment of Helicobacter pylori infection

Microb Health Dis 2021; 3 : e525
DOI: 10.26355/mhd_20218_525

  Topic: Helicobacter pylori     Category:

Loading

Dysbiosis in the small intestine: towards an optimal therapy to normalize the gut microbiota

Microb Health Dis 2021; 3 : e504
DOI: 10.26355/mhd_20217_504

  Topic: Gut microbiota     Category:

Loading

Effectiveness of antibiotics as a treatment option for adults with active Crohn’s Disease: a meta-analysis

Microb Health Dis 2021; 3 : e501
DOI: 10.26355/mhd_20217_501

  Topic: Inflammatory bowel disease     Category:

Loading

Gut microbiome pipeline – the road so far

Microb Health Dis 2021; 3 : e474
DOI: 10.26355/mhd_20214_474

  Topic: Microbiome     Category:

Loading

Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders

Microb Health Dis 2021; 3 : e472
DOI: 10.26355/mhd_20214_472

  Topic: Microbiota     Category:

Loading

The prevalence of helicobacter pylori infection in patients with epigastric pain accessing to an emergency department

Microb Health Dis 2021; 3 : e446
DOI: 10.26355/mhd_20211_446

  Topic: Helicobacter pylori     Category:

Loading

COVID-19 and fecal microbiota transplantation: limitations and potentialities are two sides of the same coin

Microb Health Dis 2021; 3 : e444
DOI: 10.26355/mhd_20211_444

  Topic: Microbiota     Category:

Loading

The microbiota and allergic (Type 2) disease: a review

Microb Health Dis 2021; 3 : e442
DOI: 10.26355/mhd_20211_442

  Topic: Microbiota     Category:

Loading

Editorial: the impairment of the intestinal microbiota: a new “disease” in “new” patients?

Microb Health Dis 2021; 3 : e440
DOI: 10.26355/mhd_20211_440

  Topic: Microbiota     Category:

Loading

Distinct composition and distribution of the gastric mycobiota observed between dyspeptic and gastric cancer patients evaluated from gastric biopsies

Microb Health Dis 2020; 2 : e340
DOI: 10.26355/mhd_20209_340

  Topic: Gastric microbiome     Category:

Loading

The role of rifaximin in irritable bowel syndrome derived from a network meta-analysis of randomized control trials

Microb Health Dis 2020; 2 : e333
DOI: 10.26355/mhd_20207_333

  Topic: Gastroenterology     Category:

Loading